Recent studies employing a model system of epithelial cell cultures and infection with pseudoviral particles carrying the spike protein of SARS-CoV-2 were able to show that sphingosine can interfere with the binding of the SARS-CoV-2 to its receptor ACE2 (Edwards et al., 2020). The gene discussed is ACE2; the disease is infection.